A detailed history of Steward Partners Investment Advisory, LLC transactions in Repligen Corp stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 58 shares of RGEN stock, worth $8,455. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58
Previous 55 5.45%
Holding current value
$8,455
Previous $10,000 30.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$120.0 - $182.95 $360 - $548
3 Added 5.45%
58 $7,000
Q4 2023

Feb 12, 2024

SELL
$114.17 - $185.35 $799 - $1,297
-7 Reduced 11.29%
55 $9,000
Q3 2023

Nov 13, 2023

BUY
$138.78 - $176.51 $971 - $1,235
7 Added 12.73%
62 $9,000
Q3 2022

Nov 10, 2022

SELL
$160.42 - $256.21 $1,764 - $2,818
-11 Reduced 16.67%
55 $10,000
Q2 2022

Aug 04, 2022

SELL
$140.68 - $188.02 $124,501 - $166,397
-885 Reduced 93.06%
66 $11,000
Q1 2022

May 02, 2022

BUY
$161.19 - $257.96 $144,426 - $231,132
896 Added 1629.09%
951 $179,000
Q2 2021

Aug 13, 2021

SELL
$165.87 - $220.95 $59,547 - $79,321
-359 Reduced 86.71%
55 $11,000
Q1 2021

May 14, 2021

BUY
$180.37 - $226.26 $53,209 - $66,746
295 Added 247.9%
414 $80,000
Q4 2020

Feb 11, 2021

SELL
$148.08 - $206.57 $4,590 - $6,403
-31 Reduced 20.67%
119 $23,000
Q3 2020

Oct 30, 2020

SELL
$122.51 - $158.27 $6,125 - $7,913
-50 Reduced 25.0%
150 $22,000
Q2 2020

Aug 06, 2020

BUY
$94.33 - $140.48 $6,131 - $9,131
65 Added 48.15%
200 $25,000
Q1 2020

Apr 29, 2020

BUY
$84.96 - $109.14 $2,973 - $3,819
35 Added 35.0%
135 $13,000
Q2 2019

Jul 25, 2019

BUY
$54.2 - $85.95 $5,420 - $8,595
100 New
100 $8,000
Q4 2018

Jan 15, 2019

SELL
$48.26 - $68.88 $4,826 - $6,888
-100 Closed
0 $0
Q3 2018

Oct 23, 2018

BUY
$46.8 - $58.97 $4,680 - $5,897
100 New
100 $6,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.09B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.